Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 2
1983 1
1984 2
1985 1
1986 6
1987 10
1988 12
1989 15
1990 33
1991 41
1992 31
1993 48
1994 59
1995 67
1996 93
1997 118
1998 117
1999 131
2000 135
2001 179
2002 258
2003 300
2004 325
2005 476
2006 499
2007 529
2008 697
2009 805
2010 892
2011 1066
2012 1235
2013 1415
2014 1820
2015 2137
2016 2445
2017 2724
2018 3252
2019 3617
2020 4339
2021 4981
2022 5859
2023 5801
2024 6216
2025 1781

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48,873 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for beijing lu
Search for Feiling Lu instead (1 results)
Theranostic application of (64)Cu/(177)Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models.
Li C, Liu J, Yang X, Yang Q, Huang W, Zhang M, Zhou D, Wang R, Gong J, Miao Q, Kang L, Yang J. Li C, et al. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):168-183. doi: 10.1007/s00259-022-05954-y. Epub 2022 Sep 5. Eur J Nucl Med Mol Imaging. 2022. PMID: 36063202
Flow cytometry and cell immunofluorescence were used to evaluate the binding ability of hIMB1636 and Trop2 on the cell surface. hIMB1636 were conjugated with p-SCN-Bn-NOTA (NOTA) and DOTA-NHS-ester (DOTA) for (64)Cu and (177)Lu radiolabeling respectively. ImmunoPET imaging …
Flow cytometry and cell immunofluorescence were used to evaluate the binding ability of hIMB1636 and Trop2 on the cell surface. hIMB1636 wer …
[(177)Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models.
Zeng Z, Li L, Tao J, Liu J, Li H, Qian X, Yang Z, Zhu H. Zeng Z, et al. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1221-1232. doi: 10.1007/s00259-023-06561-1. Epub 2023 Dec 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38062170
RESULTS: [(177)Lu]Lu-TST001 was labeled with an 99.17%0.32 radiochemical purity, an 18.50 1.27 MBq/nmol specific activity and a stability of 94% after 7 days. ...H&E showed that there was no significant short-term toxicity observed in the heart, spleen, stomach …
RESULTS: [(177)Lu]Lu-TST001 was labeled with an 99.17%0.32 radiochemical purity, an 18.50 1.27 MBq/nmol specific activity and …
Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.
Xu M, Zhang P, Ding J, Chen J, Huo L, Liu Z. Xu M, et al. J Nucl Med. 2022 Jun;63(6):952-958. doi: 10.2967/jnumed.121.262533. Epub 2021 Sep 30. J Nucl Med. 2022. PMID: 34593598 Free PMC article.
PET imaging, SPECT imaging, and biodistribution studies were performed to evaluate the pharmacokinetics in pancreatic cancer patient-derived xenograft (PDX) animal models. The cancer treatment efficacy of (177)Lu-TEFAPI-06 and (177)Lu-TEFAPI-07 were evaluated in pan …
PET imaging, SPECT imaging, and biodistribution studies were performed to evaluate the pharmacokinetics in pancreatic cancer patient-derived …
Erythema Elevatum Diutinum.
Liu J, Lu S. Liu J, et al. Am J Med Sci. 2022 Mar;363(3):e21-e22. doi: 10.1016/j.amjms.2021.07.012. Epub 2021 Sep 20. Am J Med Sci. 2022. PMID: 34547285 No abstract available.
GD2-targeted theranostics of neuroblastoma with [(64)Cu]Cu/[(177)Lu]Lu-hu3F8.
Zheng L, Li C, Yang X, Liu J, Wang G, Zhou Z, Zhu X, Gong J, Yang J. Zheng L, et al. Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1764-1777. doi: 10.1007/s00259-024-07033-w. Epub 2024 Dec 20. Eur J Nucl Med Mol Imaging. 2025. PMID: 39702399
Hu3F8 were conjugated with p-SCN-Bn-NOTA (NOTA) and p-SCN-Bn-DOTA (DOTA) for (64)Cu- and (177)Lu- radiolabelling. PET imaging and RIT studies were conducted using [(64)Cu]Cu-NOTA-hu3F8 and [(177)Lu]Lu-DOTA-hu3F8 in subcutaneous NB tumour models. ...The excell …
Hu3F8 were conjugated with p-SCN-Bn-NOTA (NOTA) and p-SCN-Bn-DOTA (DOTA) for (64)Cu- and (177)Lu- radiolabelling. PET imaging and RIT …
Detecting and genotyping high-risk human papillomavirus among male patients during 2015-2023 in Beijing, China.
Wang S, Ma QY, Du J, Wei TT, Zhang WX, Wang P, Zhou Y, Wei M, Gu L, Cui F, Lu QB. Wang S, et al. Emerg Microbes Infect. 2024 Dec;13(1):2313848. doi: 10.1080/22221751.2024.2313848. Epub 2024 Feb 13. Emerg Microbes Infect. 2024. PMID: 38318858 Free PMC article.
This study aimed to explore the detection rate and genotyping of HPV among male patients in Beijing to provide a reference for formulating prevention strategies for HPV infection. The cross-sectional study was conducted in Beijing Chaoyang Hospital from November 201 …
This study aimed to explore the detection rate and genotyping of HPV among male patients in Beijing to provide a reference for formul …
Mycobacterium tuberculosis Beijing genotype strains and unfavourable treatment outcomes: a systematic review and meta-analysis.
Liu Q, Wang D, Martinez L, Lu P, Zhu L, Lu W, Wang J. Liu Q, et al. Clin Microbiol Infect. 2020 Feb;26(2):180-188. doi: 10.1016/j.cmi.2019.07.016. Epub 2019 Jul 20. Clin Microbiol Infect. 2020. PMID: 31336202 Free article.
The rapid global spread of the Beijing genotype is receiving increasing attention because it can cause a higher risk of treatment failures. ...We included cohort studies that evaluated treatment outcomes and Beijing genotype strains. Participants were individuals wi …
The rapid global spread of the Beijing genotype is receiving increasing attention because it can cause a higher risk of treatment fai …
Optimized Therapeutic (177)Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer.
Wu Y, Zhang X, Duan X, Yang X, Wang F, Zhang J. Wu Y, et al. Pharmaceuticals (Basel). 2022 Dec 9;15(12):1530. doi: 10.3390/ph15121530. Pharmaceuticals (Basel). 2022. PMID: 36558981 Free PMC article.
Clinical trials have shown the significant efficacy of [(177)Lu]Lu-PSMA-617 for treating prostate cancer. However, the pharmacokinetic characteristics and therapeutic performance of [(177)Lu]Lu-PSMA-617 still need further improvement to meet clinical e …
Clinical trials have shown the significant efficacy of [(177)Lu]Lu-PSMA-617 for treating prostate cancer. However, the pharmac …
Erratum.
[No authors listed] [No authors listed] Interv Neuroradiol. 2015 Feb;21(1):137-8. doi: 10.1177/1591019915576685. Interv Neuroradiol. 2015. PMID: 25934789 Free PMC article.
Stent fracture and occlusion after treatment of symptomatic vertebral artery ostium stenosis with a self-expanding device: A case report by Jun Lu, Jiachun Liu, Daming Wang and Shuo Wang, Interventional Neuroradiology 2014 20: 755-760, DOI: 10.15274/INR-2014-10068. In the …
Stent fracture and occlusion after treatment of symptomatic vertebral artery ostium stenosis with a self-expanding device: A case report by …
Activity determination of (177)Lu using TDCR-Cerenkov method.
Fan Z, Liu H, Yang Z, Liang J, Sun C, Tian Y. Fan Z, et al. Appl Radiat Isot. 2025 Mar;217:111660. doi: 10.1016/j.apradiso.2025.111660. Epub 2025 Jan 6. Appl Radiat Isot. 2025. PMID: 39793435
The accuracy of measuring the activity of (177)Lu is crucial for calibrating the instruments employed in clinical applications. To support the measurements of (177)Lu solution, the existing TDCR-Cerenkov method has been extended for this nuclide. The contribution of …
The accuracy of measuring the activity of (177)Lu is crucial for calibrating the instruments employed in clinical applications. To su …
48,873 results
You have reached the last available page of results. Please see the User Guide for more information.